Job Description
- Apply technical expertise in the analysis, design, development, testing, implementation, support, and documentation of complex business applications. Ensure application systems are in compliance with standards and organizational objectives.
- Perform, maintain, and manage installs, upgrades, patch application, and troubleshooting to third-party packaged business applications, in compliance with change control procedures.
- Development of installation and validation requirements. Ensure application integration and perform unit, functional, and system tests as required.
- Manage the creation or modification of user accounts.
- Handle support tickets for third-party business applications; troubleshoot and coordinate solutions with users/vendors to close out tickets in a timely manner.
- Implement and maintain and improve monitoring, reporting and alerting.
- Collaborate with software developers, QA specialists, and other team members to ensure timely and successful delivery of new software releases.
- Performs other duties as assigned by management.
- BS in Biochemistry, Biology, Microbiology, Molecular Biology or Computer Science or other relevant discipline.
- 2 to 4 years related LIMS experience or other business applications: configuration, validation, implementation, and/or system administrator.
- Familiarity with IT systems in a Laboratory environment.
- Proficient in Windows environment.
- Experience and knowledge in the pharmaceutical and/or biotech industry within a GMP and/or GLP environments preferred.
- Some weekend work or late nights may be required periodically.
Top Skills
What We Do
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases
